ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 1 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $23,000 | 0.0% | 16,000 | -1.2% | 0.00% | – |
| Q4 2016 | $23,000 | -88.3% | 16,192 | -85.6% | 0.00% | -100.0% |
| Q3 2016 | $196,000 | -11.7% | 112,100 | -0.4% | 0.00% | -50.0% |
| Q1 2016 | $222,000 | +3.7% | 112,600 | 0.0% | 0.01% | 0.0% |
| Q4 2015 | $214,000 | -99.9% | 112,600 | +0.4% | 0.01% | -25.0% |
| Q4 2014 | $389,334,000 | -16.4% | 112,200 | +0.9% | 0.01% | -20.0% |
| Q3 2014 | $465,928,000 | +11.7% | 111,200 | +56.2% | 0.01% | +11.1% |
| Q2 2014 | $417,232,000 | -7.0% | 71,200 | 0.0% | 0.01% | -18.2% |
| Q1 2014 | $448,560,000 | +58.5% | 71,200 | +32.6% | 0.01% | +37.5% |
| Q3 2013 | $282,999,000 | -26.8% | 53,700 | +7.0% | 0.01% | -80.0% |
| Q2 2013 | $386,540,000 | – | 50,200 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $5,085,000 | 1.68% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,369,066 | $25,603,000 | 1.03% |
| Lyons Wealth Management, LLC. | 56,775 | $334,000 | 0.30% |
| Callan Capital, LLC | 66,118 | $387,000 | 0.10% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 383,050 | $2,245,000 | 0.06% |
| FCG ADVISORS, LLC | 10,600 | $62,000 | 0.05% |
| OppenheimerFunds, Inc. | 7,000,000 | $41,020,000 | 0.04% |
| NEXT Financial Group, Inc | 19,704 | $86,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 27,893,387 | $163,455,000 | 0.04% |
| MURPHY CAPITAL MANAGEMENT INC | 45,000 | $263,000 | 0.04% |